BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Min JW, Kim KW, Kim BM, Doh KC, Choi MS, Choi BS, Park CW, Yang CW, Kim YS, Oh EJ, Chung BH. Clinical Significance of Pre- and Post-Transplant BAFF Levels in Kidney Transplant Recipients. PLoS One 2016;11:e0162964. [PMID: 27631619 DOI: 10.1371/journal.pone.0162964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Friebus-Kardash J, Wilde B, Keles D, Heinold A, Kribben A, Witzke O, Heinemann FM, Eisenberger U. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival. Transpl Immunol 2018;47:10-7. [PMID: 29277566 DOI: 10.1016/j.trim.2017.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
2 Min JW, Shin YJ, Lee H, Kim BM, Park KH, Doh KC, Kim TM, Lim SW, Yang CW, Oh EJ, Chung BH. BAFF Inhibition Effectively Suppresses the Development of Anti-HLA.A2 Antibody in the Highly Sensitized Mouse Model. Int J Mol Sci 2021;22:E861. [PMID: 33467096 DOI: 10.3390/ijms22020861] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Zhang H, Wang S, Su X, Fu Q, Li J, Wang J, Deng R, Wu C, Huang Q, Liu L, Wang C. The role of soluble B cell-activating factor in further stratifying the risk of antibody-mediated rejection post-renal transplant: A meta-analysis. Int Immunopharmacol 2020;79:106059. [PMID: 31865240 DOI: 10.1016/j.intimp.2019.106059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Schuster AM, Miesgang N, Steines L, Bach C, Banas B, Bergler T. B-cell activating factor BAFF as a novel alert marker for the immunological risk stratification after kidney transplantation. Immunol Res 2021. [PMID: 34373996 DOI: 10.1007/s12026-021-09205-4] [Reference Citation Analysis]
5 Irure-Ventura J, San Segundo D, Rodrigo E, Merino D, Belmar-Vega L, Ruiz San Millán JC, Valero R, Benito A, López-Hoyos M. High Pretransplant BAFF Levels and B-cell Subset Polarized towards a Memory Phenotype as Predictive Biomarkers for Antibody-Mediated Rejection. Int J Mol Sci 2020;21:E779. [PMID: 31991734 DOI: 10.3390/ijms21030779] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Borhis G, Trovato M, Chaoul N, Ibrahim HM, Richard Y. B-Cell-Activating Factor and the B-Cell Compartment in HIV/SIV Infection. Front Immunol 2017;8:1338. [PMID: 29163465 DOI: 10.3389/fimmu.2017.01338] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Alfaro R, Jaouad EKEB, Llorente S, Jimenez-Coll V, Martínez-Banaclocha H, Galián JA, Botella C, Moya-Quiles MR, Peña-Moral J, Minguela A, Legaz I, Muro M. Personalized Medicine for Kidney Transplantation: Association of Graft Survival and Acute Transplant Rejection with Genetic Variation in B Cell Activating Factor System Signaling. OMICS 2021;25:725-37. [PMID: 34714153 DOI: 10.1089/omi.2021.0099] [Reference Citation Analysis]
8 Afzali S, Salehi S, Shahi A, Esmaeili M, Farashi Bonab S, Peykari A, Bagherpour F, Ansaripour B, Soleimanian T, Pour-Reza-Gholi F, Amirzargar A. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection. J Immunol Res 2021;2021:6654992. [PMID: 33748289 DOI: 10.1155/2021/6654992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Xu H, He X, Xu R. B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome. J Immunol Res 2018;2018:5251801. [PMID: 29977928 DOI: 10.1155/2018/5251801] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Schuster A, Jung B, Hofbauer J, Kühne L, Zecher D, Banas B, Bergler T. B-cell activating factor BAFF reflects patients' immunological risk profile after kidney transplantation. Transpl Immunol 2017;45:35-41. [PMID: 28867309 DOI: 10.1016/j.trim.2017.08.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]